Human adipose-derived stem cells (hADSCs) may provide a suitable number of progenitors for the treatment of lymphatic edema; however, to date the protocols for inducing hADSCs into this tissue type have not been standardized. We wished to investigate the induction of hADSCs into lymphatic endothelial-like cells using vascular endothelial growth factor-C156S (VEGF-C156S) and other growth factors in vitro. hADSCs from healthy adult adipose tissue were purified using enzyme digestion. Differentiation was induced using medium containing VEGF-C156S and bovine fibroblast growth factor (bFGF). Differentiation was confirmed using immunostaining for lymphatic vessel endothelial hyaluronan receptor (LYVE-1) and fms-related tyrosine kinase 4 (FLT-4), two lymphatic endothelial cell markers. The expression levels of LYVE-1, prospero homeobox 1 (PROX-1), and FLT-4 throughout induction were assessed using reverse transcriptase quantitative polymerase chain reaction. hADSCs were successfully obtained by trypsin digest and purification. Flow cytometry showed these cells were similar to mesenchymal stem cells, with a high positive rate of CD13, CD29, CD44, and CD105, and a low positive rate of CD31, CD34, CD45, and HLA-DR. Induction to lymphatic endothelial-like cells was successful, with cells expressing high levels of LYVE-1, PROX-1, and FLT-4. Adipose-derived stem cells can be induced to differentiate into lymphatic endotheliallike cells using a medium containing VEGF-C156S, bFGF, and other growth factors. This population of lymphatic endothelial-like cells may be useful for lymphatic reconstruction in the future. Commentary As an alternative to bone marrow-derived mesenchymal stem cells (BM-MSCs), Yang et al aimed to induce differentiation of Human adipose-derived stem cells (hADSCs) into a lymphatic endothelial cell phenotype. By incubating them with growth factors (e.g. bovine FGF and VEGF-C156S). It has been shown previously that adipose-derived stem cells can differentiate into many cell types. They share many qualities of bone-marrow-derived mesenchymal stem cells, and are readily available by harvesting adult fat tissue. These authors refined the technique of inducing the transformation to the lymphatic phenotype by using a mutant form of VEGF-C, VEGF-C156s, binding selectively to VEGFR3, modulating lymphangiogenesis. They demonstrated 1) a high yield of hADSCs extractable from adult adipose tissue, 2) qualitative similarities between bonemarrow derived stem cells and adipose-derived stem cells, 3) the pluripotency of these cells, differentiating into adipocytes or osteocytes (and others have shown differentiation into cartilage, muscle and endothelial cells). 4) the selective induction into lymphatic endothelial phenotype by incubation with VEGF-C156s. The authors acknowledge that they only used 3 markers to demonstrate the lymphatic phenotype (LYVE-1, PROX-1 and FLT-4) and that they did not explore the role of lymphatic specific cytokines (inducers and inhibitors). Although these findings must be further developed, the...